News

Vaccine trials among recipients of £20 million coronavirus research investment

Published on 25/03/2020
Vaccine trials among recipients of £20 million coronavirus research investment
  • Trials of new coronavirus vaccine among 6 projects to receive share of £20 million.
  • Other projects to combat coronavirus include immediately repurposing existing treatments to treat patients already diagnosed with coronavirus.
  • The UK is leading the scientific and medical response to the coronavirus outbreak

To read this article in full, please click here.

Our Valued Sponsors & Partners